Transforming basic research into new medicine is hard, time consuming, and very very expensive. The institute’s strategy will encompass the harnessing of the vast and rapidly growing wealth of life science related data, novel data mining, analysis, predictive modeling software, optimized experimental outsourcing, world class researchers, leadership, support staff, advisers, strategic partnerships, and technology toward synergistically driving translational science.

Taken together, HBI will seek to bridge the gap between discovery and pre-clinical through the innovative application of heterogeneous data sets, novel data mining and analysis tools, optimized experimental outsourcing, diverse forward looking funding strategies, and the dedication and hard work of a multidisciplinary team of dreamers and doers we will bring about a paradigm shift in translational science leading to an acceleration of therapeutics development.